Table 2.
Change in FEV1 assessments from baseline to week 12
| Parameter | Change from baseline (L)
LS mean (95% CI) |
Difference between groups (L)
LS mean (95% CI) |
p value for
non-inferiority |
|---|---|---|---|
| Pre-dose FEV1 | |||
| Fluticasone/formoterol | 0.196 (0.117, 0.275) | –0.061 (–0.161, 0.040) | 0.007 |
| Fluticasone/salmeterol | 0.257 (0.177, 0.336) | ||
| Post-dose FEV1 | |||
| Fluticasone/formoterol | 0.464 (0.374, 0.555) | –0.013 (–0.129, 0.103) | 0.002 |
| Fluticasone/salmeterol | 0.477 (0.384, 0.569) | ||
FEV1, forced expiratory volume in the first second; LS, least-squares mean.